Go With the Flow: Does Clinical Equipoise Remain for Deferral of Angiographically Intermediate Left Main Coronary Artery Disease With Hemodynamic Significance?

By sjmartinez • June 21, 2023

Chester RC, Parikh RV. Go With the Flow: Does Clinical Equipoise Remain for Deferral of Angiographically Intermediate Left Main Coronary Artery Disease With Hemodynamic Significance? Circ Cardiovasc Interv. 2023 Jun;16(6):e013113. doi: 10.1161/CIRCINTERVENTIONS.123.013113. Epub 2023 Jun 20. PMID: 37339236.

Tags: angiography, Cardiology/Epi, coronary artery disease, drug-eluting stents, Editorials, percutaneous coronary intervention, Publications

Artificial Intelligence Automation of Echocardiographic Measurements

Sahashi Y, Ieki H, Yuan V, Christensen M, Vukadinovic M, Binder-Rodriguez C, Rhee J, Zou JY, He B, Cheng P, Ouyang D. Artificial Intelligence Automation[...]

Obesity as a Chronic Disease: A Narrative Review of Evolving Definitions, Management Strategies, and Cardiometabolic Prioritization

Singh V, Sun J, Cheng S, Kwan AC, Velazquez A. Obesity as a Chronic Disease: A Narrative Review of Evolving Definitions, Management Strategies, and Cardiometabolic[...]

Artificial intelligence-guided coronary computed tomography angiography: treatment recommendations versus real-world prescriptions

Cramer SHM, Cole JH, Budoff MJ, Karlsberg RP, Gupta H, Sullenberger LE, Rahban H, Woods KM, Uzzilia JR, Purga SL, Aquino M, Knaapen P, Choi[...]